Olmenorm CTD 20mg/12.5mg Tablet
Marketer
Medicure Life Sciences India Pvt Ltd
Salt Composition
Olmesartan Medoxomil (20mg) + Chlorthalidone (12.5mg)
Overview Olmenorm CTD 20mg/12.5mg Tablet
Cardiovascullar combination therapy, like Olmenorm CTD 20mg/12.5mg tablets, effectively manages hypertension through dual-action mechanisms. Untreated hypertension significantly elevates the risk of serious complications, including stroke, myocardial infarction, and renal failure. This medication can be administered with or without food; dosage is individualized based on patient response and overall health. Consistent daily intake at the same time is crucial for optimal therapeutic efficacy. Continuous use, as directed by your physician, is essential. The formulation includes a diuretic component, potentially increasing urination, therefore avoid ingestion within four hours of bedtime. Regular use, even during symptom-free periods, is key to preventing cardiovascular events; hypertension often presents asymptomatically. Discontinuing treatment increases the risk of stroke or heart attack. Dizziness is the most frequently reported adverse effect; others may include fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is an intended pharmacological effect of the chlorthalidone component, contributing to blood pressure control. While rare, additional side effects are possible. Consult the accompanying patient information leaflet and report any persistent or bothersome side effects to your doctor; dosage adjustments or alternative therapies may be considered. This medication is contraindicated during pregnancy and requires physician consultation prior to use if you have pre-existing kidney, liver, cardiac, or diabetic conditions. Concurrent alcohol consumption may exacerbate hypotension and increase the likelihood of adverse events.
Uses of Olmenorm CTD 20mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Olmenorm CTD 20mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmenorm CTD 20mg/12.5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Olmenorm CTD 20mg/12.5mg Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use Olmenorm CTD 20mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Olmenorm CTD 20mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Olmenorm CTD 20mg/12.5mg Tablet works:
Each Olmenorm CTD 20mg/12.5mg tablet contains a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Olmenorm CTD 20mg/12.5mg tablets and alcohol can result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Olmenorm CTD 20mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmenorm CTD 20mg/12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, dizziness, blurred vision, or reduced alertness after taking Olmenorm CTD 20mg/12.5mg tablets. These side effects are possible.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmenorm CTD 20mg/12.5mg tablets, potentially requiring dosage modification. Medical advice is necessary; administration is generally inadvisable in such cases.
LiverCAUTION
Patients with liver impairment should use Olmenorm CTD 20mg/12.5mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Olmenorm CTD 20mg/12.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Olmenorm CTD 20mg/12.5mg Tablet :
Should you forget to take a dose of Olmenorm CTD 20mg/12.5mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmenorm CTD 20mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently